The Pharmaceutical Society of Ghana (PSGH) has issued a warning that drug-resistant infections could result in an estimated annual loss of $435 million to the Ghanaian economy between 2024 and 2030. This projection includes $105 million in costs to healthcare providers and $97 million in direct medical expenses for patients and caregivers. The PSGH highlighted that these figures do not account for significant losses in productivity.
According to the PSGH, antimicrobial resistance occurs when microorganisms such as bacteria, viruses, fungi, and parasites evolve to withstand medicines designed to kill or control them. This evolution makes infections harder to treat and, in some cases, impossible. The Society noted that this trend has become a major public health and development threat, leading to treatment failures, prolonged illnesses, rising healthcare costs, disabilities, and preventable deaths.
The PSGH pointed out that antimicrobial resistance could undermine routine medical procedures that depend on effective antimicrobials. These procedures include surgery, cancer treatment, organ transplantation, and childbirth. The misuse of antimicrobial medicines in agriculture, livestock farming, and aquaculture, as well as pharmaceutical waste and untreated wastewater contaminating the environment, are factors fuelling the spread of resistant microorganisms.
The consequences of antimicrobial resistance extend beyond human health, impacting food security, livelihoods, economic growth, and environmental sustainability. The PSGH urged the government and other stakeholders to strengthen the financing, coordination, and monitoring of Ghana's National Action Plan on Antimicrobial Resistance. They also recommended aligning the country's response with the updated Global Action Plan on Antimicrobial Resistance for 2026–2036.
The updated Global Action Plan on Antimicrobial Resistance, adopted at the 79th World Health Assembly in May 2026, prioritises infection prevention, vaccination, water and sanitation improvements, responsible antimicrobial use, stronger surveillance, and sustainable financing. The PSGH emphasised that pharmacists play a central role in tackling antimicrobial resistance through appropriate antimicrobial selection, dispensing, patient education, and surveillance.
The PSGH called on healthcare facilities to establish antimicrobial stewardship programmes supported by multidisciplinary teams, adequate resources, and routine monitoring. They also urged regulators to enforce measures against the improper sale of antimicrobials and the circulation of substandard or falsified medicines. Additionally, the PSGH appealed to the public to avoid self-medication and take antibiotics only on the advice of qualified health professionals.
The Society previously supported efforts to strengthen antimicrobial stewardship in Ghana, including participation in the Commonwealth Partnership for Antimicrobial Stewardship between 2018 and 2019. This initiative, run by the Tropical Health and Education Trust and the Commonwealth Pharmacists Association, trained healthcare workers as AMR stewards, champions, and fellows.
Key points
- The Pharmaceutical Society of Ghana warns that antimicrobial resistance could drain $435 million annually from the economy between 2024 and 2030.
- Antimicrobial resistance could undermine routine medical procedures such as surgery, cancer treatment, and childbirth.
- The PSGH urges stronger national coordination and financing to tackle antimicrobial resistance.